Letter to the editor: “Safety of nonsteroidal anti-inflammatory drugs in copperhead snakebite patients” by Pham and Mullins, Clin Toxicol 2018 May 18

Eric J. Lavonas; Charles J. Gerardo

doi:10.1080/15563650.2018.1502445

Letter to the editor: “Safety of nonsteroidal anti-inflammatory drugs in copperhead snakebite patients” by Pham and Mullins, Clin Toxicol 2018 May 18

Eric J. Lavonas^*, Charles J. Gerardo

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

6 Scopus citations

Original language	English
Pages (from-to)	144-145
Number of pages	2
Journal	Clinical Toxicology
Volume	57
Issue number	2
DOIs	https://doi.org/10.1080/15563650.2018.1502445
State	Published - 1 Feb 2019
Externally published	Yes

Access to Document

10.1080/15563650.2018.1502445

Cite this

@article{7d5d44a3058a47daa5f3b4a1442db2bc,

title = "Letter to the editor: “Safety of nonsteroidal anti-inflammatory drugs in copperhead snakebite patients” by Pham and Mullins, Clin Toxicol 2018 May 18",

author = "Lavonas, {Eric J.} and Gerardo, {Charles J.}",

note = "Funding Information: This letter and the analyses contained were prepared without funding support. The referenced clinical trials were supported by BTG International, Inc. and Instituto Bioclon, as stated in the respective trial publications. Denver Health and Duke University have received research grant and other funding from BTG International, and Denver Health has received research funding from Instituto Bioclon. Neither author has received funds personally, nor has other interests to declare.",

year = "2019",

month = feb,

day = "1",

doi = "10.1080/15563650.2018.1502445",

language = "English",

volume = "57",

pages = "144--145",

journal = "Clinical Toxicology",

issn = "1556-3650",

number = "2",

}

TY - JOUR

T1 - Letter to the editor

T2 - “Safety of nonsteroidal anti-inflammatory drugs in copperhead snakebite patients” by Pham and Mullins, Clin Toxicol 2018 May 18

AU - Lavonas, Eric J.

AU - Gerardo, Charles J.

N1 - Funding Information: This letter and the analyses contained were prepared without funding support. The referenced clinical trials were supported by BTG International, Inc. and Instituto Bioclon, as stated in the respective trial publications. Denver Health and Duke University have received research grant and other funding from BTG International, and Denver Health has received research funding from Instituto Bioclon. Neither author has received funds personally, nor has other interests to declare.

PY - 2019/2/1

Y1 - 2019/2/1

UR - http://www.scopus.com/inward/record.url?scp=85054860535&partnerID=8YFLogxK

U2 - 10.1080/15563650.2018.1502445

DO - 10.1080/15563650.2018.1502445

M3 - Letter

C2 - 30306814

AN - SCOPUS:85054860535

SN - 1556-3650

VL - 57

SP - 144

EP - 145

JO - Clinical Toxicology

JF - Clinical Toxicology

IS - 2

ER -

Letter to the editor: “Safety of nonsteroidal anti-inflammatory drugs in copperhead snakebite patients” by Pham and Mullins, Clin Toxicol 2018 May 18

Access to Document

Fingerprint

Cite this